RALPH STEPHEN JOHN has a total of 14 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are LDN PHARMA LTD, SHANGHAI HARVEST PHARMACEUTICAL CO LTD and AROG PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Republic of Korea | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Special acyclic compounds | |
#5 | Heterocyclic compounds | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Ralph Stephen John | 14 |
#2 | Neuzil Jiri | 6 |
Publication | Filing date | Title |
---|---|---|
KR20100135803A | Mitochondrially delivered anti-cancer compounds | |
EP2063884A1 | Pro-oxidant anti-cancer compounds | |
US2007207161A1 | Immunomodulating compositions and uses therefor |